SYSTEMATIC REVIEW article

Front. Surg., 17 October 2022

Sec. Orthopedic Surgery

Volume 9 - 2022 | https://doi.org/10.3389/fsurg.2022.983931

Sex and gender determinants following spinal fusion surgery: A systematic review of clinical data

  • 1. Complex Structure Surgical Sciences and Technologies, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy

  • 2. Spine Surgery, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy

  • 3. Scientific Direction, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy

Abstract

In the last decade, numerous studies analyzed and described the surgical outcomes in male and female patients submitted to orthopedic surgery. Although this, the impact of sex/gender on spinal fusion surgery clinical outcomes is still poorly defined. This review systematically maps and synthesizes the scientific literature on sex/gender differences in postoperative outcomes for patients undergoing spinal fusion surgery. The search was performed in PubMed, Scopus, and Web of Science in the last 22 years. Clinical studies evaluating potential sex/gender differences in postoperative outcomes and/or complications, as primary or secondary aim, were included and analyzed. Out of the 1,885 records screened, 47 studies were included. These studies comprised a total of 1,158,555 patients (51.31% female; 48.69% male). About 77% of the analyzed studies reported sex/gender-related differences in postoperative outcomes. Most studies treated patients for lumbar degenerative diseases and more than 55% of them reported a worse postoperative outcome in female patients in terms of pain, disability, health-related quality of life questionnaires, and complications. Differently, a significant heterogeneity across studies on patients treated for cervical and sacral degenerative diseases as well as for spinal deformity and traumatic spinal fracture prevented the understanding of specific sex/gender differences after spinal fusion surgery. Despite this, the present review highlighted those female patients treated for lumbar degenerative spine diseases could require more clinical awareness during postoperative care. The understanding of how sex/gender differences can really affect clinical outcomes after spinal fusion surgeries is mandatory for all spinal pathological conditions to drive clinical research toward oriented and personalized protocols.

Introduction

In the last decade, sex/gender differences attracted considerable interest in several specialties, including cardiothoracic and trauma surgery (1). These differences are key issues for a personalized treatment. The National Institutes of Health (NIH) promotes investigators to design their studies in a way that allows the participants to self-identify their sex or gender (2). By sex, we mean the biological character of male and female as opposed to gender, which reflects societal roles and expectations (2). Although, sex and gender are two different concepts, in medicine they are often linked, and, in the review, they were used as synonyms. Within orthopedic surgery, a patient's sex/gender is thought to influence outcomes after total joint arthroplasty (manly in total knee arthroplasty), after rotator cuff repair, and after anterior shoulder surgical stabilization (3). Sex-based differences in spinal disease incidence have been previously described in several studies, such as lumbar degenerative disc disease (4), lumbar radiculopathy (5), and cauda equina syndrome (6). Nevertheless, Taylor et al. (7) highlighted that male patients generally receive more recommendations than female ones for spine surgery despite similar underlying disorders (7). The impact of male or female sex/gender on clinical outcomes in spinal fusion surgery is less well defined. This is in part because most of the studies do not consider patient sex when examining demographic trends in outcomes, reporting “sex-adjusted” statistics, or using sex-matched groups. Despite this, some data demonstrated individual differences in the postoperative outcomes between male and female patients after spinal fusion surgery. In detail, several clinical trials found a better global and functional outcome after lumbar spine fusion for males than for females. A retrospective study by Gehrchen et al. (8) reported that the female gender is an independent risk factor for nonoptimal outcomes after lumbar fusion; a randomized controlled trial (9) observed that the female gender was also associated with worse postoperative results (10). However, a prospective clinical study on 4,780 patients in the Swedish National Spine Register with lumbar degenerative disc disease and chronic low back pain showed that female patients had worse pain and function preoperatively but improved more than males after surgery (11). These conflicting results are due to the fact that several of the studies are limited to small samples size, which has insufficient power to reach accurate conclusions. Regarding complications, there are several hypothetical reasons for male and female differences after spinal surgery. Differences in anthropomorphic parameters, body mass index, and comorbidity may contribute to differences in complications and mortality risks between females and males after spine surgery (1214). Additionally, specific differences in tobacco and alcohol use/abuse as well as in unhealthy lifestyles (malnutrition, unhealthy diet, drug abuse, etc.) might also increase the odds of postoperative death or the development of specific complications, such as surgical site infection (SSI) (15).

The number of studies suggesting that sex/gender may affect patient outcomes after a spinal fusion procedure begets the need for a comprehensive examination of these data. Thus, we performed a systematic review of the literature to better understand sex/gender-based differences in spinal fusion surgery outcomes. These aspects are of key interest for both physician and patient thus, to be informed about predictive gender and sex-related differences. This information could also have a prognostic value, playing a critical role in the decision-making process.

Methods

Eligibility criteria

The PICOS model (Population, Intervention, Comparison, Outcomes, Study design) was used to design this study: (1) studies that considered female and male patients (Population) submitted to, (2) spinal fusion surgery (Interventions), (3) with a comparison between them (female and male) (Comparisons), (4) that reported postoperative clinical and/or functional outcomes of spinal fusion surgery (Outcomes), in (5) randomized, retrospective, prospective and case series studies (Study design). Studies from May 2000 to May 2022 were included in this review if they met the PICOS criteria. We excluded studies that evaluated (1) surgeries other than the spine, (2) patients undergoing spine surgery with other severe pathological conditions (genetic and rare diseases, diffuse metastases, advanced neurodegenerative disorders), and (3) articles with incomplete outcomes or data. Additionally, we excluded reviews, case reports, letters, comments to editors, in vivo and in vitro studies, pilot studies, meta-analyses, editorials, protocols and recommendations, guidelines, and articles not written in English.

Search strategies

Our literature review involved a systematic search conducted in May 2022. We performed our review according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement (16). The search was carried out on three databases: PubMed, Scopus, and Web of Science Core Collection. The following combination of terms was used (spinal fusion OR spinal arthrodesis OR vertebral fusion OR vertebral arthrodesis) AND (gender differences OR sex differences OR gender-specific OR sex-specific), and for each of these terms, free words, and controlled vocabulary specific to each bibliographic database were combined using the operator “OR.” The combination of free-vocabulary and/or Medical Subject Headings (MeSH) terms for the identification of studies in PubMed, Scopus, and Web of Science Core Collection were reported in Supplementary Table S1.

Selection process

After submitting the articles to a public reference manager (Mendeley Desktop 1.19.8) to eliminate duplicates, possible relevant articles were screened using the title and abstract by three reviewers (FS, DC, and MT). Studies that did not meet the inclusion criteria were excluded from review and any disagreement was resolved through discussion until a consensus was reached, or with the involvement of a fourth reviewer (MF). Subsequently, the remaining studies were included in the final stage of data extraction.

Data collection process and synthesis methods

The data extraction and synthesis process started with cataloging the studies' details. To increase validity and avoid omitting potentially findings for the synthesis, three authors (MT, VB, and CG) extracted and performed tables taking into consideration: the study design, female and male patients' number and age, type of surgery (indication and operation types), presence of comorbidities, complications, main objectives related to sex/gender, follow-up, assessment measures, pre-and postoperative quantitative measures, complications, and outcomes/endpoints (specific sex/gender differences).

Assessment of methodological quality

The methodological quality of the selected studies was independently assessed by two reviewers (DC and FS), using the Cochrane risk-of-bias tool RoB for randomized trials and the Cochrane risk of bias ROBINS-I for nonrandomized studies of interventions (17). The tool for randomized trials included five domains, which assessed the possible sources of bias: bias arising from the randomization process, bias due to deviations from intended interventions, bias due to missing outcome data, bias in the measurement of the outcome, and bias in the selection of the reported result. For each domain were assigned one of three levels: low risk of bias, some concerns, or high risk of bias until an overall bias risk judgment is reached. The tool for nonrandomized trials included seven domains, which assessed the possible sources of bias: bias due to confounding, bias in the selection of participants into the study, bias in classification of interventions, bias due to deviations from intended interventions, bias due to missing data, bias in the measurement of the outcome, and bias in the selection of the reported result. For each domain were assigned one of three levels: low risk of bias, moderate risk of bias, or high risk of bias until an overall bias risk judgment is reached. In case of disagreement, the reviewers attempted to reach a consensus by discussion; if this failed, a third reviewer (MF) was consulted to make the final decision.

Results

Study selection and characteristics

The initial literature search retrieved 1,885 studies. Of those, 798 studies were identified using PubMed, 435 using Scopus, and 652 were found in the Web of Science Core Collection. Articles were screened for title and abstract and 100 articles were selected. Subsequently, these articles were submitted to a public reference manager to eliminate duplicates. The resulting 77 complete articles were then reviewed to establish whether the publications met the inclusion criteria, and 47 studies were considered eligible for this review. Search strategy and study inclusion and exclusion criteria are detailed in Figure 1. Of these articles, 33 were retrospective studies, 12 were prospective studies, 1 was a case series, and another 1 was a randomized clinical trial (RCT).

Figure 1

Assessment of methodological quality

In our quality assessment, the randomized trial is judged to raise some concerns, but not to be at high risk of bias for any domain. The risk of bias was mainly about the randomization process and measurement of the outcome. The 70% of the nonrandomized studies were rated at low risk of bias for all domains, 21% were rated at moderate risk of bias, and 9% were rated at critical risk of bias. Methodological weaknesses that led to moderate or weak quality scores often included bias due to confounding, missing data, deviations from intended interventions, and bias in the measurement of the outcome. Risks of bias assessments for each randomized and nonrandomized study were reported in Supplementary Tables S2 and S3.

Studies general information, objectives, and cohort characteristics

Descriptive characteristics of each study are presented in Tables 1 and 2. The included studies involved a total of 1,158,555 patients. The overall percentages of female and male patients were 51.31% and 48.69%, respectively. Apart from five studies evaluating adolescent patients, the others consider patients operated at a mean age of 55.55 ± 7.38 years. Most studies (n = 23) examined the association between sex/gender and clinical outcomes in relation to a general clinical assessment and/or to specific scores. Eighteen studies also evaluated the association between sex/gender and postoperative complications, such as intensive care unit (ICU) admission, superficial and deep SSI, postoperative fractures, cardiac events, heterotopic ossifications, instrumentation failure and reoperation rate, length of stay (LOS), or specific risk factors (opioid use, smoking, obesity). Furthermore, one study examined sex/gender differences in relation to recombinant human bone morphogenetic protein-2 (rhBMP2) use during spinal fusion surgery.

Table 1

ReferenceCountry of publicationStudy designPatients numberSex/AgeDiagnoses and surgeryComorbiditiesMain objectives related to sex/gender
Abousamra et al. (18)United StatesRetrospective837F = 697
M = 140
Mean age: 15.2 ± 2.2
AIS
Posterior fusion
NRBlood loss
Adogwa et al. (19)United StatesRetrospective13,257F = 7,871
M = 5,386
Age > 25
Degenerative diseases (symptomatic stenosis or spondylolisthesis)
Decompression and one, two, or three-level posterior lumbar instrumented fusion
Direct comparison revealed that female cohort had a higher prevalence of obesity, while males had greater proportions of type 2 diabetes mellitus, myocardial infarction, atrial fibrillationDifferences in opioid use
Alomari et al. (20)United StatesRetrospective21,180Single-level group: F = 5,026, M = 6,168
Multilevel group:
F = 4,953, M = 5,033
Single- and multilevel ACDFM: myelopathy, diabetes mellitus, hypertension, bleeding disordersPeri-op outcomes after ACDF
Alomari et al. (21)United StatesRetrospective44,526-Single-level PLF:
F = 4,705, M = 4,156
-Multilevel PLF:
F = 2,563, M = 2,291
-Single-level PLIF/TLIF: F = 7,737, M = 7,403
-Multilevel PLIF/TLIF: F = 3,481, M = 3,372
-Single-level ALIF/LLIF: F = 2,281, M = 2,139
-Multilevel ALIF/LLIF: F = 2,291, M = 2,107
Degenerative diseases
Posterior lumbar fusion, posterior/transforaminal lumbar interbody fusion, anterior/lateral lumbar interbody fusion
Females were older and functionally dependent. Male were more likely to have diabetes mellitus, hypertension, and bleeding disordersPeri-op outcomes after elective lumbar fusion spine surgery
Ayhan et al. (22)EuropeRetrospective199F = 164
M = 35
Mean age: 51.94
Scoliosis, thoracic kyphosis, degenerative or idiopathic deformityNRClinical outcomes
Basques et al. (23)United StatesRetrospective20,383F = 10,486
M = 9,897
Age > 18
Degenerative spine disease
ACDF
Male slightly older, ↑ incidence of diabetes and hypertensionDifferences in baseline characteristics and risk factors for adverse outcomes
Bumpass et al. (24)United StatesRetrospective409F = 319
Mean age: 55.0
M = 90
Mean age: 58.3
Adult spinal deformity
Primary posterior instrumented fusion ≥5 levels
NRComplications, operative morbidity, deformity x-ray correction, HRQoL
Buttermann et al. (25)United StatesProspective159101 females
58 males
Mean age: 46.4 ± 9.7
c20 of scoliosis or kyphosis ACDF with or without decompressionNRClinical outcomes after ACDF
Chan et al. (26)United StatesRetrospective477F = 159
M = 318
Grade 1 degenerative lumbar spondylolisthesisDiabetes, anxiety, coronary artery disease, osteoporosis, depressionPatients’ satisfaction
Chaichuangchok et al. (27)AsiaRetrospective54F = 19
M = 35
Mean age: 58.9 ± 12
Degenerative cervical spondylitis, myelopathy
Single- and multilevel ACDF
Diabetic mellitus, hypertension, dyslipidemiaPredictive factors for the outcomes after ACDF
Christian et al. (28)United StatesRetrospective536F = 234
M = 302
Age >65
Degenerative diseases Elective spinal surgery (PCDF, ACDF, thoracic or lumbar short segment (≤4), and thoracic or lumbar long segment (≥5) decompression and/or fusion procedures)NRAssociations between smoking and pre-op opioid consumption and their impact on post-op outcomes
Elsamadicy et al. (29)United StatesRetrospective4,972F = 3,282
M = 1,690
Adult spine deformity
Elective spine fusion surgery involving ≥4 levels
Comorbidities: alcohol use, hypertension, diabetes mellitus, overweight/obese, hypercoagulable state, heart failure, atrial fibrillation, chronic obstructive pulmonary disease, chronic kidney disease, peripheral vascular disease, liver disease.
Male cohort ↑ prevalence of comorbidities than the female cohort
LOS and discharge disposition after elective spine fusion surgery
Gulbrandsen et al. (30)United StatesRetrospective1,931F = 1,219
Mean age: 61 ± 12.83
M = 712 males
Mean age: 59 ± 14.07
Lumbar degenerative conditions and thoracolumbar deformity
Open posterior instrumented fusion
Comorbidities: autoimmune and gastrointestinal disorders, depression, fibromyalgia, thyroid disease
Females had a ↑ number of comorbidities compared to males:
F:1.75 ± 1.42
M: 1.50 ± 1.33
Recovery after spinal surgery (pain, function, complications)
Helenius et al. (31)EuropeRetrospective60F = 30
Mean age:16.2 ± 2.6
M = 30
Mean age:15.5 ± 2.3
AISNoneLong-term results of operative treatment
Hermansen et al. (32)EuropeRCT72F = 39
M = 33
Mean age: 59 ± 8.6
Degenerative radiculopathy with or without neck pain Cervical intervertebral fusion cage or Cloward procedureNRPre-op factors predicting good long-term outcomes and subgroup differences at the 10-year follow-up between patients with and without clinically relevant improvement
Heyer et al. (33)United StatesRetrospective41,315F = 20,248
Mean age: 57.27
M = 21,067
Mean age: 56.06
Different spine diseasesDiabetes, severe COPD, hypertension, revascularization/amputation for peripheral vascular disease, preoperative transfusion, bleeding disorder, previous percutaneous coronary intervention, cardiac surgery
Male: ↑ bleeding disorder, previous percutaneous coronary intervention, cardiac surgery
30-day complications
Jang et al. (34)East AsiaRetrospective208F = 104
M = 104
Mean age: 45.9
Thoracolumbar burst fracture Posterior instrumented fusionDiabetes, hypertension, heart diseases, prior brain attackRisk factors and predictors for post-op recollapse
Kay et al. (35)United StatesProspective808F = 406
M = 402
Mean age 58.1 ± 13.9
Degenerative lumbar disease (herniated disc, spondylolisthesis, spondylosis, stenosis)
Laminectomy with fusion
Coronary artery disease, hypertension, previous myocardial infarction, congestive heart failure, diabetes mellitus, depression, and anxietyPost-op ICU admission
Kaye et al. (36)United StatesRetrospective50,495Mean age: 66,75 ± 10,52 (with cardiac event) and 59,26 ± 13,58 (without cardiac event)Different spine diseases
Single-level lumbar spine fusion (arthrodesis with posterior, posterolateral, or anterior interbody technique, including minimal discectomy, laminectomy, and/or discectomy to prepare interspace)
Diabetes mellitus, congestive heart failure, renal failure, dialysis, peripheral vascular disease, chronic obstructive pulmonary disease, hypertensionIncidence and risk factors for adverse cardiac events
Khechen et al. (37)United StatesRetrospective169F = 69 females
Mean age: 54.70 ± 11.36
M = 100 males
Mean age 54.80 ± 11.32
Degenerative diseases
Minimally invasive (MIS) TLIF
F: 2.1 ± 1.94
M: 2.10 ± 1.91
Post-op improvements in patient-reported outcomes after MIS TLIF
Kim et al. (38)KoreaRetrospective485F = 329
M = 156
Mean age: 57.5
Degenerative spine diseases Partial hemilaminectomy, transpedicular screw fixation, and both posterior lumbar interbody fusion with cage and posterolateral fusionHypertension, cardiovascular diseases, renal diseases, pulmonary diseases, endocrine diseases, hepatic diseases
F: 17.6%
M: 14.7%
Complications after spinal surgery
Kothari et al. (39)United StatesProspective4,555F = 2,686
M = 1,864
Spinal fusion deformitiesComorbidities: cardiac, pulmonary, and renal comorbidity, bleeding disorder, diabetes mellitus.
Male ↑ cardiac events, bleeding disorder, diabetes mellitus
Post-op morbidity after spinal surgery
Lim et al. (40)Southest AsiaProspective296F = 202
Mean age: 52.2 ± 3.2
M = 94
Mean age: 56.1 ± 11.6
Grade 1 or 2 degenerative spondylolisthesis and nerve compression symptoms, radicular pain, paresthesia, or neurogenic claudication Single-level MIS TLIFDiabetes, ischemic heart disease, osteoarthritis, asthma, depression, hypertension, hypercholesterolemia, and renal disease.
Females ↑ prevalence of osteoarthritis
Functional, patient-reported outcome measures, health-related quality of life, satisfaction, and fulfillment of outcomes
Mai et al. (41)EuropeRetrospective10,770F = 5,714
M = 5,056
Mean age: 62 ± 15
Degenerative diseases, complex deformity corrections
Cervical interventions with anterior or posterior fusion (± instrumentation), thoracic/lumbar interventions with posterior decompression and/or spondylodesis with rigid stabilization either with posterior and/or interbody fusion (open or mini-open/MISS)
NRLOS
Maior et al. (42)RomaniaCase series44F = 17
Mean age: 37.88 ± 13.56
M = 27
Mean age: 44.04 ± 14.28
Single-level traumatic burst fracture in the thoracolumbar transition area (Th12-L2)NRHealth-related quality of life and disability after a thoracolumbar burst fracture
Malik et al. (43)United StatesRetrospective23,615F = 12,805
M = 10,810
Degenerative diseases
one- to two-level posterior lumbar fusions
Diabetes mellitus, dyspnea, history of severe chronic obstructive pulmonary disease, congestive heart failure, hypertension, dialysis-dependent, bleeding disorders
Females are more likely to be older and have dyspnea prior to surgery. Males were more likely to have diabetes and bleeding disorders
Early surgical outcomes after elective posterior lumbar fusions
Maragkos et al. (44)United StatesRetrospective131F = 78
M = 53
Mean age: 60
Degenerative spinal disease (discogenic, stenosis, spondylolisthesis), Posterolateral pedicular screw fixation with or without posterior interbody fusionDiabetes, osteoporosisRisk factors for development of adjacent segment disease
Marks et al. (45)United StatesProspective547F = 449
Mean age: 14 ± 2
M = 98
Mean age: 16 ± 2
AISNoneX-ray and perioperative surgical treatment outcomes of AIS
Nunley et al. (46)United StatesProspective389NRCervical total disc replacement and cervical anterior discectomy and fusionNREffects on outcomes, and risk factors for the development of heterotopic ossification after cervical total disc replacement
Ogihara et al. (47)East AsiaProspective2,184F = 682
M = 1,502
Mean age: 65.9
Degenerative diseases, spinal trauma, spinal tumor, or rheumatoid arthritis
Posterior cervical instrumented fusion
Diabetes mellitusIncidence of deep SSI development
Ogihara et al. (48)East AsiaProspective2,913F = 1,601
M = 1,312
Mean age: 65.9
Thoracic and/or lumbar degenerative diseases Posterior instrumented fusionDiabetes mellitusRisk factors for deep SSI
Park et al. (49)East AsiaProspective16,927F = 11,054
M = 5,873
Mean age: 62.35 ± 10.43
Degenerative lumbar disease (lumbar disc herniation, spondylolisthesis, stenosis)
Single-level decompression and fusion
Diabetes, osteoporosisReoperation rates
Park et al. (50)East AsiaProspective20,606F = 13,122
M = 7,484
Mean age: 61.86 ± 10.97
Degenerative lumbar diseases single-level fusion (posterolateral fusion or posterior/transforaminal lumbar interbody fusion)Diabetes, osteoporosisRisk factors for repeat decompression and fusions
Parrish et al. (51)United StatesRetrospective192F = 77
Mean age: 53.2 ± 10.7
M = 115
Mean age: 50.6 ± 11.0
Degenerative spine diseases (herniated nucleus pulposus, degenerative disc disease, isthmic spondylolisthesis, spondylolisthesis, foraminal stenosis)
Primary, one- or two-vertebral level MIS TLIF
Diabetes, diabetes mellitusPROMIS-PF scores
Parrish et al. (52)United StatesRetrospective75F = 33
M = 42
Mean age: 49.9 ± 10.8
Degenerative spine diseases
Primary, single-level MIS TLIF
Pre-op chronic health comorbidities: the most frequent were hypertension, arthritis, diabetesSeverity of PHQ-9 scores among patients with depressive symptoms
Poorman et al. (53)United StatesRetrospective803,949F = 410,818
M = 393,131
Mean age: 53.1
Different spine diseases
Spinal fusion, decompression of the lumbar spine (laminectomy and discectomy with fusion)
Comorbidities associated with ↑ mortality: mild and severe liver disease, congestive heart failureRates and risk factors associated with mortality
Salzmann et al. (54)United StatesRetrospective63Fracture: n = 21
-F = 16
-M = 5
-Mean age: 66.4
Non-fracture: n = 42
-F = 32
-M = 10
-Mean age: 65.3
Sacral fractures after posterior instrumented fusion
Posterior instrumented fusion
NROccurrence of post-op sacral fracture after spinal surgery
Samuel et al. (55)United StatesRetrospective62,690F = 26,818
M = 35,872
Degenerative spine diseases
Single-level discectomy, or fusion
Overweight: 34.7%
Obesity class 1: 24.9%
Obesity class 2: 12.0%
Obesity class 3: 7.7%
Rate of early failures after lumbar discectomy and associated risk factors
Schmitt et al. (56)United StatesRetrospective172F = 119
M = 53
Mean age: 61.8 ± 13.4
Long-segment fusion for adult spinal deformity correctionNRFusion rates using relatively low-dose rhBMP-2 for adult spinal deformity surgery
Shabat et al. (57)IsraelRetrospective367F:177
M: 190
Mean age: ≥65
Degenerative spine disease (spondylolisthesis)Obesity, depression, heart diseases, diabetes mellitus, osteoarthritis, peripheral vascular diseasesPatients’ satisfaction rates in lumbar spine surgery
Sharma et al. (58)United StatesRetrospective191F = 141
M = 50
Mean age: 64.3
Idiopathic, degenerative, or iatrogenic deformity
Anterior, posterior, or circumferential lumbar and thoracolumbar fusion ≥3 levels
Obesity, diabetes II, hypertension, dyslipidemiaHRQoL
Smorgick et al. (59)IsraelRetrospective163F = 128
Mean age: 15.15
M = 35
Mean age 16.17
AISNoneClinical and radiographic characteristics after AIS
Triebel et al. (11)EuropeProspective4,772F = 2,521
Mean age: 46 ± 11
M = 2,251 males
Mean age: 46 ± 10
Degenerative disc disease and chronic low back pain
Lumbar fusion
NRClinical outcomes
Ungureanu et al. (60)RomaniaProspective61F = 31
Mean age: 48.67 ± 12.70
M = 30
Mean age: 50.93 ± 14.54
Degenerative pathology
Posterior lumbar interbody fusion
NRHRQoL and disability, and correlation between the two after spinal fusion for chronic low back pain
Wang et al. a (61)East AsiaRetrospective36F = 20
M = 16
Mean age: 48.3
Cervical radiculopathy and myelopathy (revision surgery for symptomatic adjacent segment disease)
Single-level ACDF
NRIncidence and risk factors
Wang et al. b (62)East AsiaRetrospective153F = 102
M = 51
Mean age: 50.11 ± 7.48
Cervical degenerative disc disease
Continuous two- or three-level hybrid surgery (ACDF cervical disc replacement) for multilevel
NRImpact of smoking on intermediate-term outcomes
Xu et al. (63)ChinaRetrospective162F = 120 females
Mean age: 14.79
M = 42
Mean age: 16.79
AIS
Pedicle screw instrumentation and posterior fusion
NonePostoperative x-ray outcomes after AIS

Studies general information.

M, male; F, female; NR, not reported; MIS, minimally invasive surgery; MISS, minimally invasive spine surgery; AIS, adolescent patients’ treated for idiopathic scoliosis; ACDF, anterior cervical discectomy and fusion; HRQoL, health-related quality of life; TLIF, transforaminal lumbar interbody fusion; LOS, length of stay; COPD, chronic obstructive pulmonary disease; SSI, surgical site infection; PROMIS-PF, Patient-Reported Outcome Measurement Information System-Physical Function.

Table 2

Ref.FUAssessment measuresPre-op quantitative measuresPost-op quantitative measuresComplicationsSpecific sex/gender differences
Abousamra et al. (18)NRGeneral health status, x-rayNRMean magnitude of main thoracic curve = 60 ± 10 degrees. Mean measured 2D T5-T12 kyphosis = 22 ± 14 degrees and mean calculated 3D T5-T12 kyphosis = 6 ± 12 degrees.NRMale patients with severe thoracic lordosis (T5-T12 ≤ 0 degree) are the ↑ risk group for intra-op bleeding.
Adogwa et al. (19)1 year
2 years
General health statusNANANRFemale sex, obesity, preoperative narcotic use, and LOS associated with prolonged opioid use after index surgery
Alomari et al. (20)30 daysGeneral health statusNANAPeri-op blood transfusion, pulmonary embolism, deep vein thrombosis or thrombophlebitis, myocardial infarction, stroke with neurological deficit, unplanned intubation, pneumonia, deep or superficial SSI, sepsis, septic shock, deathExcept for an ↑ incidence of UTI in female patients and myocardial infarction in males, no significant differences in morbidity and mortality
Alomari et al. (21)30 daysGeneral health status, laboratory valuesNANA-Peri-op blood transfusion: F = 141, M = 110
Pulmonary embolism: F= 13, M = 12
-DVT/thrombophlebitis: F = 22, M = 18
-Myocardial infarction: F = 7, M = 132
-Stroke with neurological deficit: F = 9, M = 4
-Unplanned intubation: F = 27, M = 26
-Pneumonia: F = 66, M = 57
-UTI: F = 344, M = 27
-Deep SSI: F: 13, M = 8
-Superficial SSI: F = 27, M = 10
-Sepsis: F = 26, M = 13
-Septic shock: F = 8, M = 12
-Death: F = 26, M = 26
Increased risk for UTI in females and myocardial infarction in males, no significant differences in morbidity and mortality between males and females
Ayhan et al. (22)1 yearGeneral health status, x-ray, self-reported HRQol measures (COMI, ODI, SF-36 MCS, SF-36 PCS, SRS-22)MCCA = 40.85°
T2–T12 kyphosis = 37.68
ODI = 40.41
SF-36 MCS = 41.48
SF-36 PCS = 35.94
SRS-22 Subtotal = 2.86
MCCA = 20.86°
T2–T12 kyphosis = 45.05
ODI = 27.92
SF-36 MCS = 45.81
SF-36 PCS = 41.87
SRS-22 Subtotal = 3.53
NRGender does not have a significant effect on any of the HRQol scores
Basques et al. (23)30 daysGeneral health statusNANAPneumonia, reoperation, cardiac arrest, sepsis, unplanned intubation, ventilator for more than 48 h, deathThe male gender is associated with a greater risk of any adverse event, also severe. Males with longer operative times compared to females (127 vs. 117 min)
Bumpass et al. (24)2 yearsGeneral health status, x-ray, ODI, SF-36, SRS-22rNRNRNRMales have greater mean estimated blood loss. No gender differences in operative time, transfusion, final x-ray measurements, HRQoL, incidence of complications, also controlling for age, BMI, comorbidities, and levels fused
Buttermann et al. (25)>10 yearsVAS
ODI
x-ray
NRNRNRACDF outcomes not related to gender
Chan et al. (26)3 months
12 months
General health status, ODI, EQ-5D, NRS-LP, NRS-BPNRNRReadmission within 3 months of surgery: 9; Reoperation within 12 months: 13Female sex is associated with most satisfaction (58.4% vs. 38.5%)
Chaichuangchok et al. (27)6 months
12 months
JOA scoreJOA score: 14.1 ± 2.7JOA score: 15.9 ± 1.6Transient hoarseness and
dysphagia: n = 12
No significant
difference of surgical outcome between genders; % of improvement of male patients ↑ than female
Christian et al. (28)30 daysGeneral health statusNANAWound infections, UTI, cases of pneumonia, myocardial infarctions, and thromboembolic eventsHigher proportion of male smokers who underwent a PCDF compared to female smokers (9.93% vs. 5.98%)
Elsamadicy et al. (29)At dischargeGeneral health statusNANA↑ peri-op transfusion in female than male patients; most prevalent complication in female patients is UTI, followed by pulmonary complications, hematomas, venous thromboembolism, and myocardial infarction. Most common complication in male patients is myocardial infarction, followed by pulmonary complications, cardiac complications, UTI, venous thromboembolismGender was not an independent predictor of discharge disposition, but was independently associated with increased LOS (female)
Gulbrandsen et al. (30)6 weeks
3 months
6 months
1 year
VAS
ODI
x-ray
VAS: F = 6.54 vs. M= 6.14
ODI: F = 49.73 vs. M = 46.52
VAS: 6 weeks: F = 4.36 vs. M = 3.99
3 months, 6 months, and 1 year: no differences
NRFemales reported slightly more pain and worse function than males at the time of surgery, by 3 months no further gender differences in post-op pain or function existed
Helenius et al. (31)M: mean 14.3 years
F: mean 14.1 years
X-ray, scoliosis Research Society questionnaire, spinal mobility, and non-dynamometric trunk performance testsMean Cobb angle of the thoracic curve: 55° (range 42–83°) in the males and 56° (range 43–80°) in the females. The lumbar curves:
33° (range 10–59°) in males and 34° (range 21–64°) in females.
Final correction of the thoracic curves: 30% (range 19%–65%) in males and 33% (range 7%–71%) in females.NoneAIS provides similar short and long-term results in males and females
Hermansen et al. (32)10 yearsClinically relevant improvement (C in neck-related pain intensity (≥30-mm improvement on a VAS), CRI in neck-specific disability (≥20% improvement in Neck Disability Index—NDI), radiological factors, EQ-5D, EQoL, VASNRMedian self-efficacy scale score: M = 170.5, F = 141.5
Median CSQ score—diverting attention: M = 9.0, F = 15.0; catastrophizing: M = 0.0, F = 8.5; praying/hoping: M = 2.0, F = 9.0; increased behavioral activity: M = 14.0, F = 17.5
NR↑ neck- and arm-related pain intensity in females than males, more disability, and worse psychosocial status.
Male gender was a predictor of CRI in neck-specific disability
Heyer et al. (33)30 daysGeneral health statusNANAUTI: F = 1.96%; M = 0.89%
Transfusion: F = 12.74%; M = 8.39%
Unplanned intubation: F = 0.41%; M = 0.60%
Pneumonia: F = 0.71%; M = 0.92%
Superficial SSI: F = 0.92%; M = 0.70%
Differences in complications are present between males and females. Females were at increased risk for superficial SSI, UTI, transfusions, and longer LOS; males were at increased risk of pneumonia and reintubation
Jang et al. (34)1 yearVAS, x-ray, CT, MRI, ODIMeasured body Ht. = 18.6 mm
Body Ht. loss = 35.3%
Body wedge angle = 18.9°
Sagittal Cobb angle = 18.2°
Measured body Ht. = 26.7 mm
Body Ht. loss = 8.4%
Body wedge angle = 6.9°
Sagittal Cobb angle = 4.6°
Mean VAS score lower back pain = 3.25 ODI = 14.8
27 cases of failure of the screw-bone interface, 4 instrument failure, 2 revision surgeriesRecollapse showed ↑ a proportion of males
Kay et al. (35)1 yearGeneral health status, ODI%ODI% = 48.2 ± 15.0NREstimated blood loss = 12.2%; cardiac = 29.3%; respiratory = 19.5%; neurologic complications = 31.7%; other = 7.3%Female gender, history of coronary artery disease, myocardial infarction, chronic heart failure, age, ASA grade, estimated blood loss, and LOS associated with ICU admission
Kaye et al. (36)30 daysGeneral health statusNANAMyocardial infarction, sepsis, deathFactors associated with an increased cardiac risk after spinal fusion: age, male gender, insulin-dependent diabetes, ASA score >3, hematocrit, and smoking
Khechen et al. (37)6 weeks
12 weeks
6 months
ODI
VAS back and leg pain
ODI: F = 43.77 ± 16.38; M = 36.22 ± 15.13
VAS back: F = 6.62 ± 2.29; M = 5.90 ± 2.58
VAS leg: F = 6.20 ± 2.73; M = 5.27 ± 2.94
ODI:
−6 weeks: F = −10.62 ± 17.63; M = −7.05 ± 19.15
−12 weeks: F = −18.49 ± 17.22; M = −13.53 ± 17.29
−6 months: F = −23.60 ± 17.76; M = −21.00 ± 15.98
VAS back:
−6 weeks: F = −3.21 ± 2.94; M = −2.57 ± 3.15
−12 weeks: F = −3.63 ± 2.81; M = −2.92 ± 2.83
−6 months: F = −3.67 ± 3.24; M = −3.34 ± 3.16
VAS leg:
−6 weeks: F = −3.48 ± 3.07; M = −3.01 ± 3.36
−12 weeks: F = −3.98 ± 2.94; M = −3.39 ± 3.12
−6 months: F = −4.40 ± 3.31; M = −3.32 ± 3.04
Intraoperative: none
Inpatients: F = 2; M = 2 (altered mental status, urinary tract infection, intubation)
Gender is not associated with surgical or clinical outcomes; it is not a predictor of outcomes following MIS TLIF
Kim et al. (38)>12 monthsMacNab's criteriaNRNRNonePeri-op complications not significantly associated with gender
Kothari et al. (39)30 daysGeneral health statusNANAUnivariate analysis: F associated with ↑ intra-or post-op red blood cell transfusion, UTI, and LOS >5 days; M associated with ↑ rate of pulmonary and cardiac complications.
Multivariate analysis:
F predictor of any complication, intra- or post-op red blood cell transfusion, UTI, and LOS >5 days
Females are associated with ↑overall morbidity, i.e. for UTI, transfusion, and LOS > 5 days. Male associated with ↑incidence of pulmonary and cardiac complications
Lim et al. (40)2 years
5 years
ODI, SF-36ODI: M = 41.5 ± 18.0, F = 49.5 ± 17.3
SF-36 PCS: M = 35.6 ± 10.6, F = 31.9 ± 10.3
SF-36 MCS: M = 49.2 ± 11.7, F = 44.9 ± 12.3
NRRevision surgery: F = 9, M = 3
Inadvertent durotomy: F = 4, M = 0.
Vertebral endplate perforation: F = 1
Females are significantly younger than males at the time of surgery. At 2-year and 5-year follow-ups, no significant differences in ODI, SF-36, and pain scores between males and females
Mai et al. (41)NRGeneral health status, COMINRNRGeneral medical complications and surgical complications↑ LOS in females than males. LOS ↑ with age in females compared to males. Female gender, age, and BMI associated with a longer LOS
Maior et al. (42)1 yearSF-36v2
ODI
NRNR1 wound infection (F), 1 reinsertion of a wrongly inserted screw (M)Gender-related differences favoring men after surgical interventions for spinal fractures. Male patients scored ↑ in each item of the SF-36v2. Male patients had ↓ ODI score
Malik et al. (43)30 daysGeneral health statusNANADeep surgical site infection, superficial surgical site infection, and sepsis/septic shock. The 3 most common reoperations in men: incision and drainage hematomas/seromas/fluid collections; incision and drainage, open, of deep abscess of posterior spine; reinsertion of spinal fixation device: in female: incision and drainage, open, of deep abscess of posterior spine; incision and drainage of complex wounds; and exploration of spinal fusionFemale gender is an independent risk factor significantly associated with a LOS longer than 3 days, occurrence of any complication within 30 days, wound complications, UTI, 30-day, 30-day readmissions, and nonhome discharge. The only adverse outcome associated with male was renal complication
Maragkos et al. (44)NRGeneral health status, x-rayNRNRReoperation = 33Decompression of segments outside the fusion construct associated with ↑ adjacent segment disease rates, as well as female gender
Marks et al. (45)2 yearsx-ray, pulmonary function data, SRS questionnaireCurve magnitude: 55°±11° males and 54°±11° females, with flexibility of the primary curve ↓in males.
% Predicted of FEV: 85%±18%
in males versus 81%±16% in females; % of predicted FVC was 92%±20% in males versus 86%±16% in females.
SRS scores are similar in males and females
% correction and ratio of % correction of the primary curve to preoperative flexibility: males 57% ± 17% and 1.58, females 60% ± 18% and 1.46. ↓ correction of the primary curve at 2 years FU minimal and comparable for males and females (2° ± 6° vs. 3° ± 7°, respectively).
% Predicted FEV: 4% ± 12% in males and 5% ± 13% in females; decrease in % predicted FVC: 7% ± 13% in males and 6% ± 12% in females.
SRS scores are similar in males and females
F: 5% perioperative complications, 2% major postoperative complication, 5% minor postoperative complications
M: 8% perioperative complications, 6% major postoperative complications, 2% minor postoperative complications
X-ray and perioperative surgical treatment outcomes of AIS comparable between genders
Nunley et al. (46)7 yearsNDI
VAS neck/arm pain
SF-12
NRNRNRMales were ∼3 times more likely to develop clinically relevant heterotopic ossification than females
Ogihara et al. (47)1 yearGeneral health statusNANADeep SSIRisk factors for deep SSI: occipitocervical surgery and male gender
Ogihara et al. (48)1 yearGeneral health statusNANASSIIndependent risk factors: male gender, ASA score of ≥3, operation including thoracic spine
Park et al. (49)4.5 yearsGeneral health statusNANAReoperation: >in patients with spinal stenosis than those with lumbar disc herniationMale gender was a risk factor for reoperation
Park et al. (50)90 days to 4 yearsGeneral health statusNANANROld age, and male gender, were risk factors
Parrish et al. (51)6 weeks
3 months
6 months
1 year
General health status PROMIS-PF scoresNRNRNRNo significantly different among gender in the rate of achieving minimal clinically important difference for PROMIS-PF. Females experienced significantly more improvement in post-op PROMIS-PF scores than males at the 3-month time point
Parrish et al. (52)6 weeks 12 weeks 6 months 1 yearPHQ-9 scores, SF-12, VR-1238.7% mild (PHQ-9 score 5–9)
26.6% moderate (PHQ-9 score 10–14) 34.7% moderately severe (PHQ-9 score ≥15)
NRNRNo significant differences between genders
Poorman et al. (53)NRGeneral health statusNANAComplications with the highest mortality rates: shock and pulmonary embolismIncreased mortality in males, black, ages 65–74, and age >75
Salzmann et al. (54)≥6 monthsCTNRNRPost-op fractureBMI and female gender are risk factors for post-op sacral fractures
Samuel et al. (55)30 daysGeneral health statusNRNR2.2% reoperation within 30 days: 1.2% spine-related reoperations, including 0.8% revision lumbar discectomy, 0.3% irrigation and debridement of infection, 0.1% lumbar fusionFemale gender is at increased risk of readmission for pain or neurological symptoms
Schmitt et al. (56)2 yearsX-rayNRNRConstipation/ileus,
hyponatremia,
arrhythmia, UTI, anemia/coagulopathy,
pneumonia, transient weakness/paresthesia
superficial wound drainage/infection,
urinary retention,
hematoma, AKI,
pseudarthrosis, instrumentation failure, proximal junctional kyphosis/adjacent segment disease, wound complication/infection with revision
hemorrhage, cardiac arrest, stroke
Gender associated with fusion status,
with 79.8% of females demonstrating fusion, compared to 60.4% of men
Shabat et al. (57)1 yearVAS
Barthel index (basic activities of daily status)
VAS: F 8.8 ± 1.86, M 8.36 ± 2.12
Barthel index: F 65.82 ± 11.08, M 68.28 ± 12.38
VAS: F 3.88 ± 2.56, M 3.39 ± 2.71
Barthel index: F 81.15 ± 12.24, M 84.14 ± 11.19
n = 1 death secondary to myocardial infarction; urinary retention, exacerbation of CHF and/or COPD, and unstable angina more frequently in males; urinary tract infection and postoperative delirium more frequently in females; n = 1 depression and CVA in females.
Rate of complications similar among males
(32%) and females (28%). More than one complication
found in 30% of females and 20% of males.
Gender differences influence the satisfaction rate of lumbar spinal
stenosis surgery, with females less
satisficed than males
Sharma et al. (58)1 yearHRQoLNRImprovement in EQ-5D scores in 98 patients (51%)NRGender interacted with obesity: obese males with at higher odds of improvement when compared to nonobese males; among females, obesity did not affect the odds of improvement
Smorgick et al. (59)NoneVAS
x-ray
NRNRNonePresence of a trend toward more flexible major thoracic curves in females but no significant difference between females and males
Triebel et al. (11)1 year
2 years
General health status, Patient-Reported Outcome Measures, VAS for leg and back pain, ODI, HRQoL parameter EQ-5DNRNRNRFemales with a ↑ rate of improvement from baseline to follow-up in leg pain, back pain, HRQoL, and disability. Females with better chances of clinical improvement than men for leg pain, back pain, and ODI, but improved at a slower pace in leg pain, back pain, and disability. No gender differences in HRQoL and return to work at 1-year and 2-year post-op
Ungureanu et al. (60)1 yearSF-36v2
ODI
Female
PCS: 27.08 ± 6.96
PF: 27.97 ± 8.46
RP: 27.02 ± 6.66
BP: 28.00 ± 4.86
GH: 40.53 ± 6.37
MCS: 46.54 ± 15.26
VT: 42.06 ± 10.23
SF: 39.23 ± 12.99
RE: 40.00 ± 15.14
MH: 40.66 ± 11.23
ODI: 55.91 ± 17.6
Pain intensity: 3.29 ± 1.13
Personal care: 2.00 ± 1.26 Lifting: 3.00 ± 1.44
Walking: 2.68 ± 1.28
Sitting: 3.35 ± 1.11
Standing: 3.39 ± 1.09
Sleeping: 1.97 ± 1.38
Sex life: 2.22 ± 1.83
Social life: 2.61 ± 1.65
Traveling: 3.13 ± 1.43
Male
9.20 ± 7.05
28.32 ± 7.87
29.39 ± 9.55
29.54 ± 6.62
47.78 ± 10.45
48.52 ± 14.79
42.99 ± 10.86
38.29 ± 13.96
42.47 ± 15.02
43.89 ± 12.62
56.19 ± 17.25
3.03 ± 1.00
2.37 ± 1.25
3.33 ± 1.40
2.93 ± 1.36
2.83 ± 1.60
3.27 ± 1.20
2.00 ± 1.36
2.64 ± 1.85
2.73 ± 1.64
2.97 ± 1.56
Female
PCS:43.02 ± 9.76
PF: 44.95 ± 9.24
RP: 39.92 ± 10.03
BP: 43.78 ± 9.25
GH: 46.19 ± 10.78
MCS: 49.69 ± 9.83
VT: 51.93 ± 7.96
SF: 49.04 ± 8.92
RE: 46.06 ± 12.24
MH: 46.31 ± 9.16
ODI: 21.58 ± 15.35
Pain intensity: 1.1 ± 0.90
Personal care: 0.61 ± 0.80
Lifting: 2.13 ± 1.41
Walking: 1.00 ± 1.13
Sitting: 1.42 ± 1.31
Standing: 1.32 ± 1.38
Sleeping: 0.45 ± 0.85
Sex life: 0.83 ± 1.50
Social life: 0.90 ± 1.37
Traveling: 0.81 ± 0.95
Male
46.05 ± 10.03
46.63 ± 9.20
40.39 ± 11.20
49.39 ± 9.80
53.74 ± 9.83
53.32 ± 7.90
54.88 ± 8.88
50.66 ± 8.04
49.9 ± 10.44
50.17 ± 9.69
13.43 ± 10.33
0.97 ± 0.76
0.33 ± 0.71
1.83 ± 1.60
0.43 ± 0.63
0.80 ± 1.16
0.93 ± 1.11
0.30 ± 0.65
0.36 ± 0.99
0.23 ± 0.63
0.50 ± 0.94
NRMale improved more than females in all domains of disability at the postoperative evaluation. HRQoL improved similarly in both genders. ODI score showed a strong or moderate correlation with six of the domains of the SF-36 in males, but with only three domains in females.
Wang et al. (61)5 yearsGeneral health status, x-rayNRNRLoosening of the implant, collapse of the fusion intervertebral space, hematoma, deep infectionNo gender differences
Wang et al. (62)2 yearsGeneral health status, JOA scale, NDI, VAS for neck and arm pain, x-ray, CT, and MRINRNRNRMale gender and current smoking status are significantly associated with a 1-year fusion rate. Significant differences in the early fusion process and the 1-year fusion rate across the three smoking status groups in females
Xu et al. (63)3 monthsX-raySized main curves: F = 51.53°vs. M = 52.45°Sized main curves: F = 16.83 vs. M = 20.8°NoneComparable surgical benefits between females and males

Clinical assessment and outcomes.

NA, not applicable; CRI, Clinically relevant improvement; NDI, Neck Disability Index; ASA, American Society of Anesthesiologists physical status; COMI, Core Outcome Measures Index; PCS, physical component summary; PF, physical functioning; RP, role-physical; BP, bodily pain; GH, general health; MCS, mental component summary; VT, vitality; SF, social functioning; RE, role-emotional; MH, mental health; LOS, length of stay; UTI, urinary tract infection; HRQol, health-related quality of life; ODI, Oswestry Disability Index; SF-36, Short Form Health Survey 36; BMI, body mass index; VAS, visual analogue scale; ACDF, anterior cervical discectomy and fusion; NRS-LP, numeric rating scale for leg pain; NRS-BP, numeric rating scale for low back pain; JOA, Japanese Orthopedic Association; PCDF, posterior cervical decompression and fusion; ICU, intensive care unit; TLIF, transforaminal lumbar interbody fusion; SRS, Scoliosis Research Society; PROMIS-PF, Patient-Reported Outcome Measurement Information System-Physical Function; PHQ-9, Patient Health Questionnaire-9; COPD, chronic obstructive pulmonary disease; SRS-22, Scoliosis Research Society-22 questionnaire; MCCA, major coronal Cobb angle; EQ-5D, quality of life (QoL) parameter EQ5D; EQoL, Environmental Quality of Life; CSQ, Cognitive Style Questionnaire; FEV, forced expiratory volume; FVC, forced vital capacity; VR-12, Veterans RAND-12; SF-12, Short Form-12; AKI, acute kidney injury; CHF, chronic heart failure; CVA, Cerebrovasular accident.

Examining sex/gender differences was the primary objective in 25 (52.1%) studies while the remaining evaluated the influence of several predictors and risk factors (age, smoking history, number, and location of fusion segments, plate-to-disc distances, excessive disc space distraction, kyphotic malalignment), also including sex/gender as a secondary aim.

Comorbidities were assessed in 63.8% of the studies (n = 30). In two of these studies, no comorbidities were present. In the remaining 28 studies, different comorbidities were present that include diabetes (in 50% of included studies), cardiac diseases (25%) and/or hypertension (17.8%), blending disorders (14.2%), pulmonary diseases (10.7%), obesity and overweight (10.7%), osteoporosis (7.1%), dyslipidemia (7.1%), renal diseases (7.1%), osteoarthritis (7.1%), depression (7.1%), and others less common comorbidity, i.e., liver diseases, brain attack, vascular diseases, asthma, and anxiety. In 12/27 studies where comorbidities were present and described gender-related differences in comorbidities distribution were also reported. The major comorbidity reported in females was obesity while in males were diabetes, cardiovascular morbidities (prevalently atrial fibrillation and hypertension), and bleeding disorders.

Qualitative and quantitative measures used for patient assessment were detailed in Table 1. The Visual Analogue Scale (VAS) score for back or leg pain was used, alone or in association with other measurements, by 21.2% of the studies, the Oswestry Disability Index (ODI) by 25.5% of studies, x-ray, to evaluate pre-and postoperative sized main curves, sagittal Cobb angle, kyphosis, by 27.6% and specific patient-reported outcomes measures and standardized measure of health-related quality of life (HRQoL) by 42.5% of studies. Other less common measures used include the numeric rating scale (NRS) scores for low back pain (NRS-BP), leg pain (NRS-LP), Japanese Orthopedic Association (JOA) scale, magnetic resonance imaging (MRI), computed tomography (CT), and laboratory values. Except for one study that evaluated sex/gender differences at discharge, all other studies performed clinical assessments from 30-day of follow-up up to 10 years.

Types of spine surgery and pathological conditions

Patients were diagnosed with different spine diseases, mainly degenerative pathological conditions such as disc herniation, stenosis, spondylolysis, radiculopathy, spondylolisthesis, myelopathy (55.3%), spinal deformities as adult scoliosis or kyphosis (12.7%), adolescent idiopathic scoliosis (10.6%), degenerative and deformity conditions together (14.8%), and traumatic pathologies such as fractures (6.3%). In detail, 235,140 patients (26 studies) were treated for degenerative diseases using anterior or posterior approaches (Table 1). Of these, 17 studies were retrospective and analyzed 188,278 patients, 8 were prospective and included 46,862 patients, and 1 study was an RCT with 72 patients. A total of five studies (four retrospective and one prospective) analyzed 1,769 adolescent patients' treated for idiopathic scoliosis (AIS) using a posterior approach. Concerning adult deformities, a total of 4,714 patients were evaluated in two prospective studies and 5,752 patients in four retrospective studies, using anterior or posterior approaches. Studies that analyzed degenerative and deformity conditions together (six retrospective studies and one prospective) evaluated 910,835 patients. Finally, 315 patients (three studies) were treated for traumatic sacral or thoracolumbar fractures after posterior instrumented fusion. Of these, two studies were retrospective with 271 patients, and one study was a case series with 44 patients.

Procedures associated with spinal fusion surgery included minor, major, and complex surgeries, such as posterior lumbar interbody fusion (PLIF), hemilaminectomy, decompression, anterior cervical discectomy and fusion (ACDF), transforaminal lumbar interbody fusion (TLIF), discectomy, anterior lumbar interbody fusion (ALIF) and laminectomy (Table 1). Because the types of spine fusion surgery were not standardized across the 47 studies, it was difficult to quantify the prevalence of any single type of procedure among the studies. However, most interventions were implemented for lumbar spine procedures, through techniques such as PLIF and TLIF, followed by cervical procedures such as ACDF.

Sex/gender differences in outcomes after spinal fusion surgery

In this review, 76.6% (n = 36) of studies reported sex/gender-related differences in postoperative clinical outcomes and/or complications, while the remaining studies described comparable results between males and females (Table 2). Of these 36 studies where sex/gender differences were present, n = 21 (58.3%) were on degenerative diseases, prevalently of the lumbar spine, 13.9% were on spine deformities (1 on AIS and 4 on adult deformities), 8.4% on spine fractures, and 19.4% considered degenerative conditions and deformities together (Table 1).

Degenerative spine diseases

More than half of studies on degenerative spine diseases on the lumbar spine reported worse female experiences after spinal fusion surgery (63.8%). Kay et al. showed that the female gender was associated with an increased risk of postoperative ICU admission in patients undergoing lumbar spine surgery (35). Furthermore, Maragkos et al. also reported that female patients were 2.55 times more likely than male ones to develop adjacent segment disease requiring reoperation (44). In detail, within 30 days of follow-up female gender resulted in an independent risk factor significantly associated with a LOS longer than 3 days, occurrence of complications, including wound complications, urinary tract infection (UTI), and nonhome discharge; while the adverse outcomes associated with males were renal complication and myocardial infarction (20, 43). At the same follow-up female gender also resulted in an increased risk of readmission for pain or neurological symptoms (55). At a longer follow-up, 1 year, it was analyzed the influence that gender plays on HRQoL, disability, and the correlation between these two in patients undergoing spinal fusion for chronic low back pain (60). Results showed that male patients had higher disability scores at the preoperative evaluation but improved more than females in all domains of disability postoperatively. HRQoL improved similarly in both genders. The ODI score showed a strong or moderate correlation with six of the domains of the Short Form Health Survey 36 (SF-36) in males, but with only three domains in females (60). At the same follow-up, it was also shown that gender differences influence the satisfaction rate of lumbar spinal stenosis surgery in elderly patients (≥65 years) with female patients that had less satisfactory results than male ones (57). After 2 years of follow-up, it was shown that the female gender was also associated with prolonged opioid use (19). Several studies reported different results. Parrish et al. reported that females experienced significantly more improvement in postoperative Patient-Reported Outcome Measurement Information System-Physical Function (PROMIS-PF) score than males at the 3-month time point (51). Chan et al. reported that at 1 year of follow-up, the female gender resulted also associated with more satisfaction than males (58.4% vs. 38.5%) (26). These results were further confirmed by Triebel et al. where it was shown that females had a high rate of improvement from baseline to follow-up (2 years) in leg pain, back pain, HRQoL, and disability, in comparison to males, but it was also reported that females improve more slowly in leg pain, back pain, and disability (11). At longer follow-up (up to 4.5 years), Park et al. showed that the male gender was a risk factor for reoperation (49, 50).

In cervical degenerative diseases at 1 year of follow-up a higher percentage of improvement was detected in male patients than in females (27). This result was also confirmed at 10 years of follow-up, where it was demonstrated a higher neck- and arm-related pain intensity, more disability, and worse psychosocial status in females than in males (32). Specifically, the male gender was a predictor of clinically relevant improvement in neck-specific disability (32). Differently, Nunley et al. (46) showed that males were ∼3 times more likely to develop heterotopic ossification than females as well as they were at greater risk of any adverse event (23). Alomari et al. (21) described an increased risk for UTI in females and myocardial infarction in males. Two studies also evaluated the correlation between gender, spinal fusion surgery, and smoking. A higher proportion of male smokers who underwent posterior cervical decompression and fusion (PCDF) compared to female smokers (9.93% vs. 5.98%) was detected (28). In addition, a significant difference in the early fusion process among current smokers, former smokers, and nonsmokers was detected for male patients, but no significant differences were founded at 1-year of follow-up. For female patients, statistical differences were found in both the early fusion process and the 1-year fusion rate (62).

The only study on sex/gender differences considering thoracic spine surgery was by Ogihara et al. using a multivariate analysis that showed that male gender was significantly correlated with a higher incidence of deep SSI, although it was not a significant factor in univariate analysis (48).

Spine deformities

Of the 36 studies where sex/gender differences were evaluated, n = 4 were on adult spinal deformities. Two studies reported that female sex/gender was associated with increased postoperative morbidity compared to males; after 30 days from spinal surgery, it was observed an increased postoperative transfusion rate and complications, in particular, UTI and LOS longer than 5 days, in female patients (29, 39). Conversely, one study reported that male patients were at a greater risk for bleeding compared to females (24). Differently, from the above-mentioned studies, Schmitt et al. evaluated at 2 years of follow-up the fusion rates using relatively low-dose rhBMP-2 for the treatment of adult spinal deformity surgery, showing that gender was associated with fusion status, with 79.8% of females with a good spinal fusion compared to 60.4% of males (56).

Only one study on AIS detected gender-related differences, showing that male patients, with severe thoracic lordosis, were at a higher risk of bleeding than females (18).

Degenerative conditions and deformities

Seven studies reported sex/gender-related differences considering patients treated for degenerative conditions and deformities together. In detail, at 30 days of follow-up, Heyer et al. (33) reported postoperative differences in complications between males and females. Females were at increased risk for superficial SSI, UTI, transfusions, and longer LOS while males were at increased risk of pneumonia and reintubation (33, 41). At the same experimental time, it was also shown that the male gender was associated with an increased risk of cardiac events (36). At a longer experimental time, 1-year follow-up, it was shown that the male gender represented a risk factor for deep SSI (47).

In a study on the mortality rates after spinal fusion surgery and on factors associated with its occurrence over a 10-year follow-up, it was shown that the male gender was a risk factor significantly associated with increased mortality rates (53). In addition to complications and risk factors related to gender, Gulbrandsen et al. (30) indicated that females reported slightly more pain and worse function than males at the time of surgery. Finally, Sharma et al. also showed that in spine surgeries gender interacted with obesity at 1 year of follow-up: obese males with at higher odds of improvement when compared to nonobese males; among females, obesity did not affect the odds of improvement (58).

Spine fractures

Of the 35 studies where sex/gender differences were present, n = 3 were on spine fractures after spinal fusion surgery. One study was on sacral fractures (54), and two studies were on thoracolumbar burst fractures (34, 42). Salzmann et al. observed, at a 6-month follow-up, that female gender (76.2%), advanced age (mean, 66.4 years), and obesity were risk factors for post-op sacral fractures (54). Differently, Jang et al. showed that the male gender was a risk factor for recollapse of thoracolumbar burst fractures (34). At 1-year follow-up, Maior et al. reported that male patients have better outcomes than females after thoracolumbar burst fractures; an increased score in each item of the SF-36 in male than female patients was also observed (42).

Discussion

From an epidemiological perspective, it would be critical to understand how sex/gender differences can affect clinical outcomes after spinal fusion surgery. This aspect becomes more critical from a surgical point of view since the identification of specific sex/gender differences would offer personalized approaches for patients undergoing spinal fusion procedures. Thus, the focus of this review was to analyze clinical studies aimed at evaluating sex/gender differences following spinal fusion surgery.

Our review showed that most of the analyzed studies (76.6%) report sex/gender-related differences in postoperative clinical status, outcomes, and/or complications, while the remaining described equivalent results. Furthermore, in 38.3% of the studies where comorbidities were described gender-related differences in their distribution were reported. In the female sex, obesity was the most prevalent comorbidity while in the male sex the prevalently dominant comorbidities were diabetes, cardiovascular morbidities (prevalently atrial fibrillation and hypertension), and bleeding disorders. These differences are of critical importance and could represent potential risk factors related to gender differences (both pre-op and post-op) to be analyzed in future studies, in which it will be mandatory to analyze a larger homogeneous cohort of patients, considering specific and individual spine diseases and surgical approaches. In fact, it is important to highlight that there is significant heterogeneity across the analyzed studies in terms of pathological spine diseases (degenerative, deformity, fracture), type of the spinal level treated (cervical, thoracic, lumbar, sacral), number of levels treated, and surgical approaches. In addition, it is important to underline that none of the analyzed studies evaluated specific physiological changes related to postmenopausal status in female patients submitted to spinal fusion procedures. It is known that the direct negative effects of estrogen-deficiency on bone as well as the indirect effects of altered immune status in postmenopausal women contribute to low bone mass and bone microarchitecture destruction. These bone alterations may represent a negative prognostic factor for the success of spinal fusion surgery.

In this review, most of the studies where sex/gender-related differences were present were on the patient treated for lumbar degenerative diseases (disc degeneration, disc herniation, and spondylolisthesis). Of those more than half reported a worse postoperative outcome in terms of pain, disability, HRQoL, and complications in female patients, while the remaining reported worse outcomes in terms of HRQoL and satisfaction in male patients. In studies examining pain, disability, and HRQoL differences between females and males, the complexity of evaluating these parameters which include many clinical signs and subjective outcomes must be considered. Undoubtedly, females treated for lumbar degenerative disease reported the worst postoperative scenario, but the perception and measurements of pain and disability have been debated and investigated: some studies concluded that females had lower perception thresholds and pain thresholds than males (64). This worst postoperative state in female patients is probably the reason for the prolonged postoperative opioid consumption associated with this gender (19). However, epidemiological studies have indicated that analgesic use may vary between males and females, suggesting that opioid use was higher in the female gender in general adult populations (65, 66). This systematic review found that females were also at increased risk of complications (UTI, readmission for pain or neurological symptoms, adjacent segment disease), and consequent longer LOS, following spinal fusion surgery for lumbar degenerative disease (20, 43, 44, 55). These postoperative complications may also have a link to the long-term opioid use detected in female patients. While for degenerative lumbar spine diseases a potential link between gender and clinical outcomes resulted more evident, for degenerative diseases of the cervical and thoracic spine this link is not so clear. This is probably due to the heterogenicity of the analyzed studies but also to the small number of studies found in this review. However, at 10-year to 13-year of follow-up, a prospective randomized study indicated that predictive factors of good outcome after ACDF included initial high neck-related pain intensity, nonsmoking status at the time of surgery, and male gender (32). On the contrary, other clinical studies indicated that males were more likely to develop clinically relevant heterotopic ossification than females as well as a greater risk of any adverse event, also severe (23). Similar contradictory results were also found after spinal deformity surgery, when degenerative diseases and deformities were considered and analyzed together and following spine fractures (sacral fractures and thoracolumbar burst fractures). Also, in these cases, the limited number of studies and the heterogeneity between studies remained critical factors that limit the interpretation of the results. For adult spinal deformities, a gender difference was founded by using relatively low-dose rhBMP-2 with the female gender demonstrating a better spinal fusion compared to of male one (56). In this study, there were substantial differences between the patient's series and those in the comparison groups. When degenerative diseases and deformities were considered and analyzed together it was also shown that gender interacted with obesity at 1 year of follow-up; obese males showed a higher odd of improvement when compared to nonobese males while among females, obesity did not affect the odds of improvement (58). Nevertheless, it should be noted that numerous studies present in the literature did not investigate and analyze spinal fusion outcomes dichotomizing by gender, thus it is difficult to establish a real conclusion and draw definitive results. As such, a true systematic review was not feasible. Furthermore, some limitations of this review warrant discussion. Most eligible studies in this review were retrospective and only one RCT on 47 analyzed studies was found and included. Additionally, many included studies had a small sample size and may be underpowered to identify significant clinical responses. Numerous studies, accounting for most patients, were prevalently published by groups in the United States; cultural discrepancies in patient-reported clinical assessment scores may differ geographically. The clinical assessment tools used to determine the postoperative outcomes are, prevalently, subjective patient-reported measures. Results were also difficult to interpret due to specific differences in spine diseases in the retrieved studies; for example, insufficient heterogenic data were retrieved for cervical and sacral degenerative diseases, spinal deformities, and traumatic spinal fractures. Furthermore, also searching for “spinal fusion” and “sex” or “gender” on the www.clinicaltrialg.gov website (accessed on 22 May 2022) no clinical trials had, as a primary or secondary outcome, the analysis of sex/gender differences.

Conclusions

The review highlighted those female patients treated for lumbar degenerative spine diseases probably require more clinical awareness during postoperative care. The understanding of how sex/gender differences can really affect clinical outcomes after spinal fusion surgeries have the potential to enhance clinical decision-making and care practices and may be crucially important in the context of providing patient personalized care, a critical field of contemporary medical practice.

Statements

Data availability statement

The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding author.

Author contributions

FS, DC, and MF contributed to the conceptualization of the study and to the writing—original draft preparation. FS, DC, MT, VB, and CG contributed to the methodology and data curation. FS, DC, AG, and MF contributed to the writing—review, and editing. AG and MF contributed to the supervision. MF contributed to the funding acquisition. All authors contributed to the article and approved the submitted version.

Funding

This work was supported by grants from IRCCS Istituto Ortopedico Rizzoli (Ricerca Corrente), by 5X1000 2019 project entitled “Medicina rigenerativa e riparativa personalizzata per le patologie dei tessuti muscolo-scheletrici e la chirurgia ricostruttiva ortopedica” (PRWEB: 2021/730567).

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fsurg.2022.983931/full#supplementary-material.

References

  • 1.

    LegatoMJJohnsonPAMansonJE. Consideration of sex differences in medicine to improve health care and patient outcomes. JAMA. (2016) 316(18):18656. 10.1001/jama.2016.13995

  • 2.

    NIH policy on sex as a biological variable. Available at:https://orwh.od.nih.gov/sex-gender/nih-policy-sex-biological-variable(Accessed May 22, 2022).

  • 3.

    MacDonaldSJCharronKDBourneRBNaudieDDMcCaldenRWRorabeckCH. The John Insall Award: gender-specific total knee replacement: prospectively collected clinical outcomes. Clin Orthop Relat Res. (2008) 466(11):26126. 10.1007/s11999-008-0430-1

  • 4.

    SchoenfeldAJNelsonJHBurksRBelmontPJJr. Incidence and risk factors for lumbar degenerative disc disease in the United States military 1999–2008. Mil Med. (2011) 176(11):13204. 10.7205/milmed-d-11-00061

  • 5.

    SchoenfeldAJLaughlinMBaderJOBonoCM. Characterization of the incidence and risk factors for the development of lumbar radiculopathy. J Spinal Disord Tech. (2012) 25(3):1637. 10.1097/BSD.0b013e3182146e55

  • 6.

    SchoenfeldAJBaderJO. Cauda equina syndrome: an analysis of incidence rates and risk factors among a closed North American military population. Clin Neurol Neurosurg. (2012) 114(7):94750. 10.1016/j.clineuro.2012.02.012

  • 7.

    TaylorBACasas-GanemJVaccaroARHilibrandASHanscomBSAlbertTJ. Differences in the work-up and treatment of conditions associated with low back pain by patient gender and ethnic background. Spine (Phila Pa 1976). (2005) 30(3):35964. 10.1097/01.brs.0000152115.79236.6e

  • 8.

    GehrchenPMDahlBKatonisPBlymePTøndevoldEKiaerT. No difference in clinical outcome after posterolateral lumbar fusion between patients with isthmic spondylolisthesis and those with degenerative disc disease using pedicle screw instrumentation: a comparative study of 112 patients with 4 years of follow-up. Eur Spine J. (2002) 11(5):4237. 10.1007/s00586-002-0401-2

  • 9.

    EkmanPMöllerHShalabiAYuYXHedlundR. A prospective randomised study on the long-term effect of lumbar fusion on adjacent disc degeneration. Eur Spine J. (2009) 18(8):117586. 10.1007/s00586-009-0947-3

  • 10.

    EkmanPMöllerHHedlundR. Predictive factors for the outcome of fusion in adult isthmic spondylolisthesis. Spine (Phila Pa 1976). (2009) 34(11):120410. 10.1097/BRS.0b013e3181a19e66

  • 11.

    TriebelJSnellmanGSandénBStrömqvistFRobinsonY. Women do not fare worse than men after lumbar fusion surgery: two-year follow-up results from 4,780 prospectively collected patients in the Swedish National Spine Register with lumbar degenerative disc disease and chronic low back pain. Spine J. (2017) 17(5):65662. 10.1016/j.spinee.2016.11.001

  • 12.

    CahillKSChiJHDayAClausEB. Prevalence, complications, and hospital charges associated with use of bone-morphogenetic proteins in spinal fusion procedures. JAMA. (2009) 302(1):5866. 10.1001/jama.2009.956

  • 13.

    SchoenfeldAJOchoaLMBaderJOBelmontPJJr. Risk factors for immediate postoperative complications and mortality following spine surgery: a study of 3475 patients from the National Surgical Quality Improvement Program. J Bone Joint Surg Am. (2011) 93(17):157782. 10.2106/JBJS.J.01048

  • 14.

    ShenYSilversteinJCRothS. In-hospital complications and mortality after elective spinal fusion surgery in the United States: a study of the nationwide inpatient sample from 2001 to 2005. J Neurosurg Anesthesiol. (2009) 21(1):2130. 10.1097/ANA.0b013e31818b47e9

  • 15.

    SchoenfeldAJReamerENWynkoopEIChoiHBonoCM. Does patient sex affect the rate of mortality and complications after spine surgery? A systematic review. Clin Orthop Relat Res. (2015) 473(8):247986. 10.1007/s11999-014-4102-z

  • 16.

    TugwellPToveyD. PRISMA 2020. J Clin Epidemiol. (2021) 134:A56. 10.1016/j.jclinepi.2021.04.008

  • 17.

    Cochrane training. Available at:https://training.cochrane.org/handbook/current(Accessed September 4, 2022).

  • 18.

    AbousamraOSponsellerPDLonnerBSShahSAMarksMCCahillPJet alThoracic lordosis, especially in males, increases blood loss in adolescent idiopathic scoliosis. J Pediatr Orthop. (2019) 39(3):e2014. 10.1097/BPO.0000000000001264

  • 19.

    AdogwaODavisonMAVuongVDesaiSALillyDTMorenoJet alSex differences in opioid use in patients with symptomatic lumbar stenosis or spondylolisthesis undergoing lumbar decompression and fusion. Spine (Phila Pa 1976). (2019) 44(13):E8007. 10.1097/BRS.0000000000002965

  • 20.

    AlomariSLiuAWestbroekEWithamTBydonALoSFL. Effect of patient’s sex on early perioperative outcomes following anterior cervical discectomy and fusion. J Clin Neurosci. (2021) 93:24752. 10.1016/j.jocn.2021.09.015

  • 21.

    AlomariSLiuAWestbroekEWithamTBydonALoSFL. Influence of sex on early outcomes of elective lumbar fusions: an updated propensity-matched and subgroup analysis. World Neurosurg. (2021) 150:e38899. 10.1016/j.wneu.2021.03.025

  • 22.

    AyhanSYukselSNabiyevVAdhikariPVilla-CasademuntAPelliseFet alThe influence of diagnosis, age, and gender on surgical outcomes in patients with adult spinal deformity. Global Spine J. (2018) 8(8):8039. 10.1177/2192568218772568

  • 23.

    BasquesBAHijjiFYKhechenBHawsBEMayoBCMasselDHet alSex differences for anterior cervical fusion: complications and length of stay. Spine (Phila Pa 1976). (2018) 43(15):102530. 10.1097/BRS.0000000000002512

  • 24.

    BumpassDBLenkeLGGumJLShaffreyCISmithJSAmesCPet alMale sex may not be associated with worse outcomes in primary all-posterior adult spinal deformity surgery: a multicenter analysis. Neurosurg Focus. (2017) 43(6):E9. 10.3171/2017.9.FOCUS17475

  • 25.

    ButtermannGR. Anterior cervical discectomy and fusion outcomes over 10 years: a prospective study. Spine (Phila Pa 1976). (2018) 43(3):20714. 10.1097/BRS.0000000000002273

  • 26.

    ChanAKBissonEFBydonMGlassmanSDFoleyKTPottsEAet alWomen fare best following surgery for degenerative lumbar spondylolisthesis: a comparison of the most and least satisfied patients utilizing data from the Quality Outcomes Database. Neurosurg Focus. (2018) 44(1):E3. 10.3171/2017.10.FOCUS17553

  • 27.

    ChaichuangchokCNitisingAPhonwijitLJetjumnongC. Factors predicting outcomes of anterior cervical discectomy and fusion in cervical spondylotic myelopathy: a prospective study. J Med Assoc Thai. (2017) 100(4):96.

  • 28.

    ChristianZKYoussefCAAounSGAfuwapeOBarrieUJohnsonZDet alSmoking has a dose-dependent effect on the incidence of preoperative opioid consumption in female geriatric patients with spine disease. J Clin Neurosci. (2020) 81:1737. 10.1016/j.jocn.2020.09.066

  • 29.

    ElsamadicyAAFreedmanIGKooABDavidWBLeeMKundishoraAJet alInfluence of gender on discharge disposition after spinal fusion for adult spine deformity correction. Clin Neurol Neurosurg. (2020) 194:105875. 10.1016/j.clineuro.2020.105875

  • 30.

    GulbrandsenMTLaraNBeauchampJAChungAChangMCrandallD. Early gender differences in pain and functional recovery following thoracolumbar spinal arthrodesis. J Clin Med. (2021) 10(16):3654. 10.3390/jcm10163654

  • 31.

    HeleniusIRemesVYrjönenTYlikoskiMSchlenzkaDHeleniusMet alDoes gender affect outcome of surgery in adolescent idiopathic scoliosis?Spine (Phila Pa 1976). (2005) 30(4):4627. 10.1097/01.brs.0000153347.11559.de

  • 32.

    HermansenAHedlundRVavruchLPeolssonA. Positive predictive factors and subgroup analysis of clinically relevant improvement after anterior cervical decompression and fusion for cervical disc disease: a 10- to 13-year follow-up of a prospective randomized study: clinical article. J Neurosurg Spine. (2013) 19(4):40311. 10.3171/2013.7.SPINE12843

  • 33.

    HeyerJHCaoNAAmdurRLRaoRR. Postoperative complications following orthopedic spine surgery: is there a difference between men and women?Int J Spine Surg. (2019) 13(2):12531. 10.14444/6017

  • 34.

    JangHDBangCLeeJCSohJWChoiSWChoHKet alRisk factor analysis for predicting vertebral body recollapse after posterior instrumented fusion in thoracolumbar burst fracture. Spine J. (2018) 18(2):28593. 10.1016/j.spinee.2017.07.168

  • 35.

    KayHFChotaiSWickJBStonkoDPMcGirtMJDevinCJ. Preoperative and surgical factors associated with postoperative intensive care unit admission following operative treatment for degenerative lumbar spine disease. Eur Spine J. (2016) 25(3):8439. 10.1007/s00586-015-4175-8

  • 36.

    KayeIDWagnerSCButlerJSSebastianAMorrisseyPBKeplerC. Risk factors for adverse cardiac events after lumbar spine fusion. Int J Spine Surg. (2018) 12(5):63843. 10.14444/5079

  • 37.

    KhechenBHawsBEPatelDVCardinalKLGuntinJASinghK. Does gender influence postoperative outcomes in minimally invasive transforaminal lumbar interbody fusion?Clin Spine Surg. (2019) 32(2):E10711. 10.1097/BSD.0000000000000735

  • 38.

    KimICHurJWKwonKYLeeJJLeeJWLeeHK. The efficacy and perioperative complications associated with lumbar spinal fusion surgery, focusing on geriatric patients in the Republic of Korea. J Korean Neurosurg Soc. (2013) 54(4):3238. 10.3340/jkns.2013.54.4.323

  • 39.

    KothariPLeeNJLevenDMLakomkinNShinJISkovrljBet alImpact of gender on 30-day complications after adult spinal deformity surgery. Spine (Phila Pa 1976). (2016) 41(14):11338. 10.1097/BRS.0000000000001499

  • 40.

    LimWSRLiowMHLGohGSYeoWLingZMYueWMet alWomen do not have poorer outcomes after minimally invasive lumbar fusion surgery: a five-year follow-up study. Int J Spine Surg. (2020) 14(5):75661. 10.14444/7108

  • 41.

    MaiDBrandCHaschtmannDPirvuTFeketeTFMannionAF. Non-medical factors significantly influence the length of hospital stay after surgery for degenerative spine disorders. Eur Spine J. (2020) 29(2):20312. 10.1007/s00586-019-06209-5

  • 42.

    MaiorTUngureanuGKakucsCBerceCPetrushevBFlorianIS. Influence of gender on health-related quality of life and disability at 1 year after surgery for thoracolumbar burst fractures. Global Spine J. (2018) 8(3):23743. 10.1177/2192568217710854

  • 43.

    MalikATJainNYuEKimJKhanSN. Is there a “sex effect” in 30-day outcomes after elective posterior lumbar fusions?World Neurosurg. (2018) 120:e42833. 10.1016/j.wneu.2018.08.097

  • 44.

    MaragkosGAAtesokKPapavassiliouE. Prognostic factors for adjacent segment disease after L4-L5 lumbar fusion. Neurosurgery. (2020) 86(6):83542. 10.1093/neuros/nyz241

  • 45.

    MarksMPetcharapornMBetzRRClementsDLenkeLNewtonPO. Outcomes of surgical treatment in male versus female adolescent idiopathic scoliosis patients. Spine (Phila Pa 1976). (2007) 32(5):5449. 10.1097/01.brs.0000256908.51822.6e

  • 46.

    NunleyPDCavanaughDAKerrEJ3rdUtterPACampbellPGFrankKAet alHeterotopic ossification after cervical total disc replacement at 7 years—prevalence, progression, clinical implications, and risk factors. Int J Spine Surg. (2018) 12(3):35261. 10.14444/5041

  • 47.

    OgiharaSYamazakiTShiibashiMChikudaHMaruyamaTMiyoshiKet alRisk factors for deep surgical site infection after posterior cervical spine surgery in adults: a multicentre observational cohort study. Sci Rep. (2021) 11(1):7519. 10.1038/s41598-021-87110-4

  • 48.

    OgiharaSYamazakiTShiibashiMChikudaHMaruyamaTMiyoshiKet alRisk factors for deep surgical site infection following posterior instrumented fusion for degenerative diseases in the thoracic and/or lumbar spine: a multicenter, observational cohort study of 2913 consecutive cases. Eur Spine J. (2021) 30(6):175664. 10.1007/s00586-020-06609-y

  • 49.

    ParkMSJuYSMoonSHKimTHOhJKSungPSet alReoperation rates after posterior lumbar spinal fusion surgery according to preoperative diagnoses: a national population-based cohort study. Clin Neurol Neurosurg. (2019) 184:105408. 10.1016/j.clineuro.2019.105408

  • 50.

    ParkMSJuYSMoonSHKimTHOhJKLimJKet alRepeat decompression and fusions following posterolateral fusion versus posterior/transforaminal lumbar interbody fusion for lumbar spondylosis: a national database study. Sci Rep. (2019) 9(1):4926. 10.1038/s41598-019-41366-z

  • 51.

    ParrishJMJenkinsNWHrynewyczNMBrundageTSSinghK. The influence of gender on postoperative PROMIS physical function outcomes following minimally invasive transforaminal lumbar interbody fusion. J Clin Orthop Trauma. (2020) 11(5):9105. 10.1016/j.jcot.2020.04.007

  • 52.

    ParrishJMJenkinsNWMasselDHRushAJ3rdParrishMSHrynewyczNMet alThe perioperative symptom severity of higher patient health questionnaire-9 scores between genders in single-level lumbar fusion. Int J Spine Surg. (2021) 15(1):6273. 10.14444/8007

  • 53.

    PoormanGWMoonJYWangCHornSRBeaubrunBMBonoOJet alRates of mortality in lumbar spine surgery and factors associated with its occurrence over a 10-year period: a study of 803,949 patients in the nationwide inpatient sample. Int J Spine Surg. (2018) 12(5):61723. 10.14444/5076

  • 54.

    SalzmannSNMillerCOCarrinoJAYangJShueJSamaAAet alBMI and gender increase risk of sacral fractures after multilevel instrumented spinal fusion compared with bone mineral density and pelvic parameters. Spine J. (2019) 19(2):23845. 10.1016/j.spinee.2018.05.021

  • 55.

    SamuelAMMorseKLovecchioFMazaNVaishnavASKatsuuraYet alEarly failures after lumbar discectomy surgery: an analysis of 62 690 patients. Global Spine J. (2021) 11(7):102531. 10.1177/2192568220935404

  • 56.

    SchmittPJKelleherJPAilonTHellerJEKasliwalMKShaffreyCIet alLong-segment fusion for adult spinal deformity correction using low-dose recombinant human bone morphogenetic protein-2: a retrospective review of fusion rates. Neurosurgery. (2016) 79(2):21221. 10.1227/NEU.0000000000001194

  • 57.

    ShabatSFolmanYArinzonZAdunskyACatzAGepsteinR. Gender differences as an influence on patients’ satisfaction rates in spinal surgery of elderly patients. Eur Spine J. (2005) 14(10):102732. 10.1007/s00586-004-0808-z

  • 58.

    SharmaATanenbaumJEHogueOMehdiSVallabhSHuEet alPredicting clinical outcomes following surgical correction of adult spinal deformity. Neurosurgery. (2019) 84(3):73340. 10.1093/neuros/nyy190

  • 59.

    SmorgickYNassarMTamirETalSMirovskyYAneksteinY. Clinical and radiographical characteristics in male and female adolescent idiopathic scoliosis surgical candidates. Isr Med Assoc J. (2019) 21(3):2136.

  • 60.

    UngureanuGChituAIancuIKakucsCMaiorTFlorianIS. Gender differences in the self-assessment of quality of life and disability after spinal fusion for chronic low back pain at a neurosurgical center in Eastern Europe. Neurospine. (2018) 15(3):2618. 10.14245/ns.1836076.038

  • 61.

    WangFHouHTWangPZhangJTShenY. Symptomatic adjacent segment disease after single-lever anterior cervical discectomy and fusion: incidence and risk factors. Medicine (Baltimore). (2017) 96(47):e8663. 10.1097/MD.0000000000008663

  • 62.

    WangHMengYLiuHWangXHongY. The impact of smoking on outcomes following anterior cervical fusion-nonfusion hybrid surgery: a retrospective single-center cohort study. BMC Musculoskelet Disord. (2021) 22(1):612. 10.1186/s12891-021-04501-4

  • 63.

    XuXWangFZhouXChengYWeiXBaiYet alComparison of radiographic postoperative outcomes between males and females with AIS. Medicine (Baltimore). (2015) 94(41):e1616. 10.1097/MD.0000000000001616

  • 64.

    BartleyEJFillingimRB. Sex differences in pain: a brief review of clinical and experimental findings. Br J Anaesth. (2013) 111(1):528. 10.1093/bja/aet127

  • 65.

    RileyJL3rdRobinsonMEWiseEAMyersCDFillingimRB. Sex differences in the perception of noxious experimental stimuli: a meta-analysis. Pain. (1998) 74(2–3):1817. 10.1016/s0304-3959(97)00199-1

  • 66.

    HurleyRWAdamsMCB. Sex, gender, and pain: an overview of a complex field. Anesth Analg. (2008) 107:30917. 10.1213/01.ane.0b013e31816ba437

Summary

Keywords

spinal fusion surgery, clinical data, systematic review, sex, gender differences

Citation

Salamanna F, Contartese D, Tschon M, Borsari V, Griffoni C, Gasbarrini A and Fini M (2022) Sex and gender determinants following spinal fusion surgery: A systematic review of clinical data. Front. Surg. 9:983931. doi: 10.3389/fsurg.2022.983931

Received

01 July 2022

Accepted

16 September 2022

Published

17 October 2022

Volume

9 - 2022

Edited by

Ziya Levent Gokaslan, Brown University, United States

Reviewed by

Luca Ambrosio, Campus Bio-Medico University, Italy John Charles Rotondo, University of Ferrara, Italy

Updates

Copyright

*Correspondence: Deyanira Contartese

Specialty Section: This article was submitted to Orthopedic Surgery, a section of the journal Frontiers in Surgery

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics